FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3005064604> ?p ?o ?g. }

• W3005064604 abstract "H-ferritin (HFn) nanocarrier is emerging as a promising theranostic platform for tumor diagnosis and therapy, which can specifically target tumor cells via binding transferrin receptor 1 (TfR1). This led us to investigate the therapeutic function of TfR1 in GC. The clinical significance of TfR1 was assessed in 178 GC tissues by using a magneto-HFn nanoparticle-based immunohistochemistry method. The therapeutic effects of doxorubicin-loaded HFn nanocarriers (HFn-Dox) were evaluated on TfR1-positive GC patient-derived xenograft (GC-PDX) models. The biological function of TfR1 was investigated through in vitro and in vivo assays. TfR1 was upregulated (73.03%) in GC tissues, and reversely correlated with patient outcome. TfR1-negative sorted cells exhibited tumor-initiating features, which enhanced tumor formation and migration/invasion, whereas TfR1-positive sorted cells showed significant proliferation ability. Knockout of TfR1 in GC cells also enhanced cell invasion. TfR1-deficient cells displayed immune escape by upregulating PD-L1, CXCL9, and CXCL10, when disposed with IFN-γ. Western blot results demonstrated that TfR1-knockout GC cells upregulated Akt and STAT3 signaling. Moreover, in TfR1-positive GC-PDX models, the HFn-Dox group significantly inhibited tumor growth, and increased mouse survival, compared with that of free-Dox group. TfR1 could be a potential prognostic and therapeutic biomarker for GC: (i) TfR1 reversely correlated with patient outcome, and its negative cells possessed tumor-aggressive features; (ii) TfR1-positive cells can be killed by HFn drug nanocarrier. Given the heterogeneity of GC, HFn drug nanocarrier combined with other therapies toward TfR1-negative cells (such as small molecules or immunotherapy) will be a new option for GC treatment." @default.
• W3005064604 created "2020-02-14" @default.
• W3005064604 creator A5006559236 @default.
• W3005064604 creator A5007931235 @default.
• W3005064604 creator A5017993198 @default.
• W3005064604 creator A5018652161 @default.
• W3005064604 creator A5019618399 @default.
• W3005064604 creator A5023277894 @default.
• W3005064604 creator A5026970877 @default.
• W3005064604 creator A5035512909 @default.
• W3005064604 creator A5043819331 @default.
• W3005064604 creator A5048385740 @default.
• W3005064604 creator A5054909215 @default.
• W3005064604 creator A5056495676 @default.
• W3005064604 creator A5059641714 @default.
• W3005064604 creator A5075640750 @default.
• W3005064604 creator A5079618096 @default.
• W3005064604 creator A5091103390 @default.
• W3005064604 date "2020-02-05" @default.
• W3005064604 modified "2023-10-09" @default.
• W3005064604 title "TfR1 binding with H-ferritin nanocarrier achieves prognostic diagnosis and enhances the therapeutic efficacy in clinical gastric cancer" @default.
• W3005064604 cites W1495555752 @default.
• W3005064604 cites W192179675 @default.
• W3005064604 cites W1981421409 @default.
• W3005064604 cites W1983015819 @default.
• W3005064604 cites W1995594551 @default.
• W3005064604 cites W1996697333 @default.
• W3005064604 cites W2006358233 @default.
• W3005064604 cites W2008564265 @default.
• W3005064604 cites W2020131167 @default.
• W3005064604 cites W2023427658 @default.
• W3005064604 cites W2027437657 @default.
• W3005064604 cites W2029445916 @default.
• W3005064604 cites W2032036028 @default.
• W3005064604 cites W2033520317 @default.
• W3005064604 cites W2041521061 @default.
• W3005064604 cites W2051452929 @default.
• W3005064604 cites W2053844565 @default.
• W3005064604 cites W2075302528 @default.
• W3005064604 cites W2076614074 @default.
• W3005064604 cites W2081845177 @default.
• W3005064604 cites W2092206294 @default.
• W3005064604 cites W2094736478 @default.
• W3005064604 cites W2098719201 @default.
• W3005064604 cites W2113935263 @default.
• W3005064604 cites W2115890515 @default.
• W3005064604 cites W2141297251 @default.
• W3005064604 cites W2145135839 @default.
• W3005064604 cites W2146834306 @default.
• W3005064604 cites W2153839710 @default.
• W3005064604 cites W2169560977 @default.
• W3005064604 cites W2272984102 @default.
• W3005064604 cites W2343890020 @default.
• W3005064604 cites W2439671617 @default.
• W3005064604 cites W2558219863 @default.
• W3005064604 cites W2613352698 @default.
• W3005064604 cites W2765143265 @default.
• W3005064604 cites W2774533844 @default.
• W3005064604 cites W2785462855 @default.
• W3005064604 cites W2795569119 @default.
• W3005064604 cites W2889646458 @default.
• W3005064604 cites W2922524042 @default.
• W3005064604 cites W2942376604 @default.
• W3005064604 cites W551869 @default.
• W3005064604 doi "https://doi.org/10.1038/s41419-020-2272-z" @default.
• W3005064604 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7002446" @default.
• W3005064604 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32024821" @default.
• W3005064604 hasPublicationYear "2020" @default.
• W3005064604 type Work @default.
• W3005064604 sameAs 3005064604 @default.
• W3005064604 citedByCount "37" @default.
• W3005064604 countsByYear W30050646042020 @default.
• W3005064604 countsByYear W30050646042021 @default.
• W3005064604 countsByYear W30050646042022 @default.
• W3005064604 countsByYear W30050646042023 @default.
• W3005064604 crossrefType "journal-article" @default.
• W3005064604 hasAuthorship W3005064604A5006559236 @default.
• W3005064604 hasAuthorship W3005064604A5007931235 @default.
• W3005064604 hasAuthorship W3005064604A5017993198 @default.
• W3005064604 hasAuthorship W3005064604A5018652161 @default.
• W3005064604 hasAuthorship W3005064604A5019618399 @default.
• W3005064604 hasAuthorship W3005064604A5023277894 @default.
• W3005064604 hasAuthorship W3005064604A5026970877 @default.
• W3005064604 hasAuthorship W3005064604A5035512909 @default.
• W3005064604 hasAuthorship W3005064604A5043819331 @default.
• W3005064604 hasAuthorship W3005064604A5048385740 @default.
• W3005064604 hasAuthorship W3005064604A5054909215 @default.
• W3005064604 hasAuthorship W3005064604A5056495676 @default.
• W3005064604 hasAuthorship W3005064604A5059641714 @default.
• W3005064604 hasAuthorship W3005064604A5075640750 @default.
• W3005064604 hasAuthorship W3005064604A5079618096 @default.
• W3005064604 hasAuthorship W3005064604A5091103390 @default.
• W3005064604 hasBestOaLocation W30050646041 @default.
• W3005064604 hasConcept C126322002 @default.
• W3005064604 hasConcept C142724271 @default.
• W3005064604 hasConcept C18150654 @default.
• W3005064604 hasConcept C185592680 @default.
• W3005064604 hasConcept C22814914 @default.
• W3005064604 hasConcept C2778319317 @default.
• W3005064604 hasConcept C2780035454 @default.

• next